Crossover Study to Compare Pharmacokinetic Property of SYP-1512 Tab and Revlimid Cap in Healthy Male Volunteers
Clinical trial NCT03208218 · COMPLETED
Trial details
- NCT number
- NCT03208218
- Sponsor
- Samyang Biopharmaceuticals Corporation
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2016-08-17
- Primary completion
- 2016-08-25
- Enrollment
- 42
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.